Future prospects: who is the patient who still dies of prostate cancer following local treatment of high-risk prostate cancer? Can we prolong their lives using modern treatment approaches?

Future prospects: who is the patient who still dies of prostate cancer following local treatment of high-risk prostate cancer? Can we prolong their lives using modern treatment approaches?

PURPOSE OF REVIEW: Prostate cancer remains the commonest nondermatological cause of cancer in Western men and the second leading cause of cancer death in these men. While low and intermediate-risk prostate cancers make up the vast bulk of prostate cancer diagnoses, it is high-risk prostate cancer t...

पूर्ण विवरण

ग्रंथसूची विवरण
मुख्य लेखकों:	Ayres, B, Sooriakumaran, P
स्वरूप:	Journal article
भाषा:	English
प्रकाशित:	2013

समान संसाधन

Who makes the decision? Malaysian healthcare professionals' views on prostate cancer treatment
द्वारा: Lee, Yew Kong, और अन्य
प्रकाशित: (2014)

Robotic HIFU for the treatment of prostate cancer
द्वारा: Ng, Choong Kheng
प्रकाशित: (2008)

Quality of evidence for treatment of prostate cancer.
द्वारा: Clarke, M
प्रकाशित: (2000)

The protecT (prostate testing for cancer and treatment) study: Evaluating screening and treatment of clinically localised prostate cancer in the UK
द्वारा: Hamdy, F, और अन्य
प्रकाशित: (2006)

The Prostate Testing for Cancer and Treatment (ProtecT) study: what have we learnt?
द्वारा: Hamdy, F
प्रकाशित: (2017)

ANTI-ANDROGENS IN TREATMENT OF PROSTATE-CANCER - REPLY
द्वारा: Dalesio, O, और अन्य
प्रकाशित: (1995)

The oncologic role of local treatment in primary metastatic prostate cancer.
द्वारा: Ghadjar, P, और अन्य
प्रकाशित: (2014)

Apples and oranges: comparison of treatment methods for prostate cancer using biochemical recurrence as an endpoint.
द्वारा: Sooriakumaran, P, और अन्य
प्रकाशित: (2012)

Management of prostate cancer. Part 1: chemoprevention.
द्वारा: Sooriakumaran, P
प्रकाशित: (2006)

Endorectal MRI: Use in Prostate Cancer
द्वारा: Srivastava, A, और अन्य
प्रकाशित: (2012)

Prostate volume and its correlation with histopathological outcomes in prostate cancer.
द्वारा: Sooriakumaran, P, और अन्य
प्रकाशित: (2011)

Re: Effect of dutasteride on the risk of prostate cancer
द्वारा: Sooriakumaran, P, और अन्य
प्रकाशित: (2010)

An MRI compatible manipulator for prostate cancer detection and treatment
द्वारा: DeVita, Lauren M
प्रकाशित: (2008)

Transcriptional mediators of treatment resistance in lethal prostate cancer
द्वारा: He, Meng Xiao, और अन्य
प्रकाशित: (2022)

Transcriptional mediators of treatment resistance in lethal prostate cancer
प्रकाशित: (2021)

Association of diabetes mellitus with prostate cancer: nested case-control study (Prostate testing for cancer and treatment study).
द्वारा: Turner, E, और अन्य
प्रकाशित: (2011)

Experiences of follow-up after treatment in patients with prostate cancer: a qualitative study.
द्वारा: O'Brien, R, और अन्य
प्रकाशित: (2010)

Who can best recruit to randomized trials? Randomized trial comparing surgeons and nurses recruiting patients to a trial of treatments for localized prostate cancer (the ProtecT study).
द्वारा: Donovan, J, और अन्य
प्रकाशित: (2003)

A multi-institutional analysis of perioperative outcomes in 106 men who underwent radical prostatectomy for distant metastatic prostate cancer at presentation
द्वारा: Sooriakumaran, P, और अन्य
प्रकाशित: (2016)

Prostate cancer /
द्वारा: 375298 Cramer, Scott D.
प्रकाशित: (2007)

Availability of WHO essential medicines for cancer treatment in Botswana
द्वारा: Martei, YM, और अन्य
प्रकाशित: (2018)

Nuclear 'Missiles' that can smash prostate cancer /
द्वारा: 324763 Akumanyi, Kofi
प्रकाशित: (1997)

Impact of intrafractional prostate motion on the accuracy and efficiency of prostate cancer treatment on CyberKnife radiotherapy
द्वारा: De Armas, Ricardo Eduardo
प्रकाशित: (2015)

Prostate cancer detection in men aged 45-49 years in the UK protect (prostate testing for cancer and treatment) trial
द्वारा: Hamdy, F, और अन्य
प्रकाशित: (2006)

Treatment of advanced localised prostatic cancer by orchiectomy, radiotherapy, or combined treatment. A Medical Research Council Study. Urological Cancer Working Party--Subgroup on Prostatic Cancer.
द्वारा: Fellows, G, और अन्य
प्रकाशित: (1992)

Management of prostate cancer. Part 3: metastatic disease.
द्वारा: Shah, J, और अन्य
प्रकाशित: (2006)

Who still dies young in a rich city? Revisiting the case of Oxford
द्वारा: Brimblecombe, N, और अन्य
प्रकाशित: (2020)

Can androgen receptor levels in the prostate predict non-organ-confined prostate cancer?
द्वारा: Hamdy, F
प्रकाशित: (2005)

An autocrine loop for vascular endothelial growth factor is established in prostate cancer cells generated after prolonged treatment with interleukin 6.
द्वारा: Steiner, H, और अन्य
प्रकाशित: (2004)

Prostate specific antigen based biennial screening is sufficient to detect almost all prostate cancers while still curable.
द्वारा: Hugosson, J, और अन्य
प्रकाशित: (2003)

Prostate-cancer mortality at 11 years of follow-up.
द्वारा: Schröder, F, और अन्य
प्रकाशित: (2012)

Angiogenesis and the tumour hypoxia response in prostate cancer: a review.
द्वारा: Sooriakumaran, P, और अन्य
प्रकाशित: (2005)

Prostate cancer and microfluids
द्वारा: Bernstein, Darryl Ethan, और अन्य
प्रकाशित: (2021)

BUTCHERS AND PROSTATE-CANCER
द्वारा: Kinlen, L
प्रकाशित: (1987)

Staging in prostate cancer.
द्वारा: Wilkinson, B, और अन्य
प्रकाशित: (2002)

Screening for prostate cancer.
द्वारा: Carlsson, S, और अन्य
प्रकाशित: (2012)

Prostate cancer 2000.
द्वारा: Bodmer, W
प्रकाशित: (2000)

Metastasis of prostate cancer /
द्वारा: 172762 Ablin, Richard J., और अन्य
प्रकाशित: (2007)

On the use of prostate-specific antigen for screening of prostate cancer in European Randomised Study for Screening of Prostate Cancer.
द्वारा: Bangma, C, और अन्य
प्रकाशित: (2010)

Patient-reported outcomes following treatment for localized prostate cancer: Helping decision making for patients and their physicians.
द्वारा: Hamdy, F, और अन्य
प्रकाशित: (2017)